Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded ...

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today shared more data on the ...

Hims & Hers Health, a telehealth company, is planning to offer a generic version of Novo Nordisk's diabetes drug, liraglutide ...

To quote a 2014 paper by Lewellen and Resutek, "firms with higher accruals tend to be less profitable in the future". Hims & Hers Health has an accrual ratio of -0.32 for the year to September 2024.

The project marks the first healthcare Public-Private Partnership in Central Asia and aims to set new standards for green ...

highlighting brands like HIMS. “During [the pandemic] you had a heightened awareness of wellness,” said Marie Driscoll, a ...

IntelePeer, a leading AI-powered Communications Automation provider, has today announced the availability of its SmartAgent and SmartOffice solutions, powered by the latest in generative AI technology ...

EchoStor Technologies, a leading technology solutions provider, today announced that CRN, a brand of The Channel Company, has named EchoStor a 2024 Triple Crown Award winner. This elite recognition is ...

Teladoc Health (NYSE: TDOC) has struggled to navigate a shifting landscape in the virtual care industry. At the time of ...

ICD is investing EUR 40 million for the construction and operation of a 630-bed multidisciplinary hospital in the city of ...

Unleashing A New Era in Affiliate Measurement for Marketers WorldwideNEW YORK--(BUSINESS WIRE)--#Adobe--PartnerCentric, a ...

Buy HIMS near 22.19 target 27.44 stop loss @ 22.13 Details The technical summary data tells us to buy HIMS near 22.19 with an ...